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Summary.-The reaction of the hepatocarcinogen N,N-dimethylnitrosamine has
been compared with that of methyl methanesulphonate, a methylating agent which
is not a liver carcinogen. Consistent differences have been observed in the reaction
of rat liver DNA in vivo with these agents; 06-alkylation and the production of
unidentified acid-labile products were distinctive features of the reaction with the
carcinogenic nitroso compound but were undetectable or in low yield, respectively,
after reaction with the alkyl sulphonate. Evidence has been obtained for the
excision of these reaction products in animals treated with the hepatocarcinogen
and the significance of their relative stabilities is discussed.
CELLULAR nucleic acids are known to
react with carcinogens, but in order to
deduce the role of these reactions in the
carcinogenic process a more precise know-
ledge must be obtained of the various
cellular reaction sites, and particularly of
the stability of the reaction products in
vivo. To answer these questions, experi-
mental conditions must be sought that
allow these parameters to be followed
without interference from degradative
changes caused by the toxicity of these
agents in vivo. In the present report, a
comparison is made of the methylation of
liver DNA in rats treated with either the
hepatic carcinogen N,N-dimethylnitro-
samine (DMN) or methyl methanesul-
phonate (MMS) which is not known to
be carcinogenic in rat liver. Using the
low dosages detailed in the text, we have
already presented evidence that the turn-
over of rRNA in rat liver cells in vivo is
not altered for at least 14 days (McElhone,
O'Connor and Craig, 1971; M. J. Capps,
1972). The incorporation of metabolic
label into DNA reported in the present
paper suggests that turnover of DNA
labelled by this process is not increased
by these dosages. Thus, under these
prescribed conditions of minimal toxi-
city it should be possible to examine
the way in which liver cells deal with
modifications to their DNA structure and
to assess the stability of the methylation
products in vivo. One limiting factor,
however, is the low level of reaction
products that are obtained at some of the
minor sites of methylation. An account
of the reaction products obtained with
DMN and MMS in rat liver rRNA has
already been given (O'Connor et al.,
1972).
MATERIALS ANI) METHODS
Materials.-[MIe4C]Methyl methanesul-
phonate (56 mCi/mmol) and di['4C]methy-
lamine hydrochloride (220 mCi/mmol) were
obtained from the Radiochemical Centre,
Amersham, Bucks. Labelled MMS was dis-
solved in 09%o NaCl for injection (0-915
mCi/mmol) and N,N-di[14C]methylnitrosa-
mine (3 34 mCi/mmol) was prepared from
di['4C]methylamine hydrochloride by the
method of Dutton and Heath (1956). In
the preparation of these agents the
appropriate amounts of pure unlabelledP. J. O'CONNOR, M. J. CAPPS AND A. W. CRAIG
chemicals were added to the original radio-
active samples.
For column chromatography, Dowex-
50W-X4 (-400 mesh) and Dowex-AGI-X8
(200-400 mesh) were purchased from Biorad
Laboratories, Richmond, California. Pan-
creatic deoxyribonuclease (purified) was
obtained from the Worthington Biochemical
Corpn., Freehold, N.J.; Escherichia coli
alkaline phosphatase (Type III S) and
crude snake venom (Crotalus adamanteus)
were obtained from Sigma Chemical Co.,
London. The crude snake venom was
partially purified as described earlier
(O'Connor et al., 1972). The following
marker compounds were supplied by Sigma
Chemical Co. Ltd: 7-methylguanine,
3-methylcytosine, 3-methyladenine and 1-
methyladenine; 7-methyladenine was
obtained from Cyclo Chemicals, Los Angeles,
California and O6-methyldeoxyguanosine and
3-methylguanine were kindly supplied by
Dr P. D. Lawley.
Animals.-Male Wistar rats were given
single intrapeiitoneal injections and were
allowed access to food and water throughout
these experiments. Rats (230-250 g) were
injected with MMS between 10.30 and
11.00 a.m. and rats (210-220 g) were injected
with DMN at 11.00 a.m. In both cases
animals were killed by decapitation without
anaesthesia at the times indicated in the
text.
Purification of DNA.-Livers were
removed, rinsed in ice cold NaCl (0-9% w/v),
weighed, frozen on solid CO2 and stored at
-70°C. DNA was isolated as described by
Kirby and Cook (1967) and stored as a dry
felt at -15°C. The procedure was checked
for the absence of RNA by digesting DNA
with venom phosphodiesterase and bacterial
alkaline phosphatase. The constituent
nucleosides were chromatographed on a
column (10 cm x 1 cm) of Dowex-l(formate
form) using an exponential gradient (10
mmol/l NH40H-30 mmol/l ammonium for-
mate, pH 4.2). The order of elution in this
system was deoxycytidine, deoxyadenosine,
thymidine, uridine and deoxyguanosine.
Hydrolysis of DNA.-Samples were
hydrolysed with 72% HC1O4 (W/V) (50
,ul/mg) for 1 hour at 100°C and diluted to 2 ml
with water for column chromatography.
Mild hydrolytic procedures were carried out
(a) by incubation in 2 ml 0.1 mol/l HCI for
16 hours at 37°C; (b) by incubation in 1 ml
H20 with 20 ,ul pancreatic deoxyribonuclease
(1 mg/ml) for 1 hour at 37°C to reduce the
viscosity and then byincubation for 18 hours
at 37°C with partially purified venom phos-
phodiesterase (0i22 u) in the presence of 0.1
mol/l tris-HCl (pH 89), 2 mmol/l MgC12
and bacterial alkaline phosphatase (8-4 u),
the total volume was 2 ml. Samples were
diluted to 3 ml with water for application
to the column. Enzyme hydrolysates were
tested for completeness by chromatography
of a portion of the digest on Polygram CEL
300 UV, Macherey-Nagel and Co., Duren,
Germany, using solvent (3) as described earlier
(O'Connor et al., 1972).
Column chromatography of hydrolysates
of DNA.-Procedure A: Samples of acid
hydrolysates ofDNA were applied to columns
of Dowex-50(H+, form, 28 cm x 1 cm) which
were equilbrated with 0 75 mol/l HC1.
Columns were developed at a flow rate of
15 ml/hour using a convex gradient 0 75
mol/l-2.5 mol/l HCI; the volume of the
mixing vessel was 200 ml and fractions
(6 ml) were collected. Procedure B: Mild
acid or enzymic hydrolysates were applied to
columns of Dowex-50(NH4+, form, 70 0
cm x 1-5 cm) which had been equilibrated
with 0 3 mol/l ammonium formate (pH 8.9)
and were developed at a flow rate of 15 ml/
hour, with the same solution; fractions (8 ml)
were collected. UV absorption was
monitored at 254 nm with a Uvicord photo-
meter (LKB Instruments, S. Croydon, Surrey)
and measured accurately with a Uvicam SP
3000 spectrophotometer (Pye-Unicam, Cam-
bridge). Radioactivity was assayed as
described.
Paperchromatography.-Radioactivemeth-
ylated bases were identified by paper
chromatography as described previously
(O'Connor et al., 1972). The solvents
employed were (1) n-butanol: aq NH3 (sp.
gr. 0.88) : water (85: 2: 12, by vol); (2)
methanol : conc. HCI: water (7 : 2: 1, by
vol) and (3) propan-2-ol : aq NH3 (sp. gr.
0.88) : water (7 :1: 2, by vol). Identifi-
cation of 3-methylcytosine, 1-methyladenine
and 7-methyladenine was made by chromato-
graphy ofthe samples in 2 directions, descend-
ing with solvent (1) and ascending with
solvent (2). In the case of 3-methylguanine,
separation was achieved by ascending chrom-
atography in solvent (2). In all cases areas
of the paper corresponding to the appro-
priate markers and adjacent control areas
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were assayed for radioactivity as described.
For the separation of 7-methylguanine from
3-methyladenine ascending chromatography
was used with solvent (2); descending
chromatography was employed for the follow-
ing: peak (X1) in solvent (1), 06-methyl-
guanine and 3-methyladenine in solvent
(3). For these last 3 separations the entire
paper was cut into 1-cm strips for assay of
radioactivity.
Determination of radioactivity.-Samples
(4 ml) from the Dowex-50(H+, form) column
effluents were blended with 6 ml of a scintil-
lation mixture composed of 1 part Triton
X-100 and 1 part of toluene phosphor
(2,5-diphenyloxazole, 16 g/l, and 1,4-bis-
(5-phenoloxazol-2-yl)benzene, 04 g/l, in AR
toluene). Samples (3 ml) from the Dowex-
50(NH4+, form) column effluents were blended
with 6 ml of the toluene phosphor mixture
and 12 ml of Triton X-100 in the presence
of0-2 ml 2 NHCI. Paper strips were counted
as described earlier (O'Connor et al., 1972). A
background counting rate was determined
for each vial and the efficiency of counting
was determined by using an internal stan-
dard. Samples were assayed for radio-
activity in a Nuclear Chicago or a Packard
spectrometer.
RESULTS
Methylation of DNA in vivo
Injections of MMS (50 mg/kg body
weight) and DMN (2 mg/kg) were given
by the intraperitoneal route. For an
assessment of the initial reaction with
DNA, animals were killed at 4 and 5
hours respectively after the injection.
Methylation by MMS was about 50%0 com-
plete by the first 15 minutes and was
maximal between 2 and 4 hours. With
DMN, methylation was maximal by 5
hours, in agreement with the results of
Craddock and Magee (1963). The incor-
poration of radioactivity by metabolic
pathways was small and was detected
only in thymine, guanine and adenine.
After treatment with MMS, reaction with
DNA after 4 hours yielded 04 ,amol
['4C]methyl groups/g and 0.05%0 of the
guanine residues were converted to 7-
methylguanine. Corresponding values for
DMN at 5 hours were 0 5 /xmol and 0 050°0.
The difference in the extent ofmethylation
relative to the reaction with guanine was
due to the different distribution of methy-
lated products, in particular to the early
peak (X1). In calculating the extent of
reaction, allowance has been made for the
radioactivity incorporated by metabolic
pathways and on the assumption that the
specific activity of the [14C]methyl group
remained unchanged.
Analysis of methylation products
Methods of analysis were carried out
essentially as described by Lawley and
Shah (1972). Two procedures for column
chromatography were employed. Strong
HCIO4 hydrolysates were loaded on to
columns of Dowex-50(H+, form) which
were eluted with an exponential gradient
of HCI (Procedure A). Mild acid and
enzymic Hydrolysates were applied to
columns of Dowex-50(NH4+, form) for
elution with ammonium formate buffer
(Procedure B). Details are given in the
Materials and Methods section.
Strong acid hydrolysis of DNA.-The
patterns of methylation obtained by
reaction of DNA in vivo with the two
methylating agents MMS and DMN have
been compared after HC1O4 hydrolysis
of the isolated DNA and subsequent
chromatographyofthe product on columns
of Dowex-50(H+, form) (Fig. 1 and 2a;
Table I). Differences were observed in
the molar proportions of the major
modified base 7-methylguanine and also
for 3-methyladenine (Table I); both were
present in larger amounts after treatment
with MMS. The molar proportions of
the minor products 3-methylcytosine,
3-methylguanine (recently isolated by
Lawley and Orr, 1970), 1-methyladenine
and 7-methyladenine that chromato-
graphed in the position of the corres-
ponding marker compounds were very
similar and all were of the order of 1% or
less of the total methylation products.
An earlier report on the methylation of
rat liver DNA (Lawley et at., 1968)
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TABLE I.-Products from the in vivo Methylation of Rat Liver DNA by [14C]MMS or
[14C]DMN. The Molar Proportions of the Products are Expressed as aPercentage of
the Total Radioactivity Recovered from the Columns after Making a Correction for the
Metabolic Incorporation ofRadioactivity into Thymine, Guanine and Adenine
Method of HC
hydrolysis
Method of a
analysis
Products
X1 1*9
3-methylcytosine 0 4
3-methylguanine 0-9
1-methyladenine 0- 7
7-methyladenine 0-6
7-methylguanine
95.5
3-methyladenine J
06-methylguanine
4C]methyl methanesulpho
C104 HC104 0 1
a+c a a+c
1*9
0-7
0-6
1-3
1-2
88-5)
92-3
79 4
7.5J 12-9 7-2
not
detected
11
nate N,N-di[14C]methylnitrosamine
NHCI HC104 HC104 0.1 NHCl Venom
phosphc
diesterase
b a a+c a b b
28-8
0 3
0 8
0 7
0-4
}68-0
65-8
2-2
22-4
1.0
1.0
1-2
1.0
}72-9
- 4 0
4-4
2-6
6-1
Time after 4 hours
injection
The methods of chromatography employed are denoted as (a)
(b) Dowex-50(NH4+, form) column and (c) paper chromatography to
7-methylguanine after elution from a column ofDowex-50(H+, form).
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FIG. 1.-Ion exchange chromatography on Dowex-50(H+, form) of a HC104 hydrolysate of DNA
isolated from the livers of rats killed 4 hours after an injection of [14C]MMS (50 mg/kg). Details
of the chromatography are given in the text; 0,E1
" (some base line points have been omitted); *, radioactivity; positions of the bases are indicated as follows: Thy, thymine; Cyt, cytosine;
3-MeCyt, 3-methylcytosine; Gua, guanine; 3-MeGua, 3-methylguanine; 7-MeGua, 7-methyl-
guanine; 3-MeAde, 3-methyladenine; l-MeAde, l-methyladenine; Ade,adenine; 7-MeAde, 7-methyl-
adenine: X1 is discussed in the text.
ll 'dt - 0000 - o-
_
olHEPATOCARCINOGEN N,N-DIMETHYLNITROSAMINE IN VIVO
E o 2 CO
wi
157
E
U
E
aU
0
%C
Fraction No
(a)
2
E a, .2w I
?~Thy f~Ade
Ii Il~~Gu
10 0~~~~~~.1
.0. I;
0 0.0.0.0. ~ ~ ua II.-,,00000000000o--- '...........
0 20 40
E
2 _.O
U eV
0
(Uto
1 z
x
60
Fraction No
(b)
FIG. 2. Ion exchange chromatography on Dowex-50(H+, form) of a HCl04 hydrolysate of DNA
isolated from the livers of rats killed (a) 5 hours or (b) 21 days after an injection of [14C]DMN
(2 mg/kg). Details are described under Fig. 1.
using [14C]DMN (27 mg/kg) indicated
somewhat higher levels of methylation of
3-methylcytosine, 1-methyladenine and
3-methyladenine, but in that study pro-
ducts corresponding to the early peak were
not detected.
The early peak (Table I, Fig. 1 and 2a)
contains about 10 times more labelledP. J. O'CONNOR, M. J. CAPPS AND A. W. CRAIG
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FIG. 3.-Ion exchange chromatography on Dowrex-50(NH4+, form) of an enzymic hydrolysate of
DNA isolated from the livers of rats killed 5 hours after an injection of [;4C]DMN (2 mg/kg).
Details ofthe chromatography are given in the text; positions of the major nucleosides are indicated
as follows: dT, thymidine; dC, deoxycytidine; dG, deoxyguanosine; (1A, deoxyadenosine and
06-MledG for the marker 06-methyl(ieoxyguanosine.
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FiG. 4. Ion exchange chromatography on Dowex-50(NH4+, form) of a mild acid hydrolysate of DNA isolated from the livers of rats killed at (a) 5 hours, (b) 24 hours, or (c) 48 hours after an injection of [14C]DMN (2 mg/kg). Py, indicates the position of the pyrimidine oligonucleotides; positions of the major bases are denoted as in Fig. 1 and the position of the marker base 06-methyl- guanine is shown as 06-MeGua. This marker was added as the deoxynucleoside at the beginning of the hydrolysis period.P. J. O'CONNOR, M. J. CAPPS AND A. W. CRAIG
material after reaction with DMN than
after reaction with MMS. This repre-
sents the principal difference between
these two treatments that was revealed by
this method of analysis. The radioactive
materials contained in this early peak
were examined by paper chromatography
in solvent (1). In this system, 80%
remained at the origin, 60% moved with
an Rf value of 0-08 and the remainder
co-chromatographed with thymine.
Mild hydrolysis of DNA. The methy-
lation product O6-methylguanine has been
shown to be labile during strong acid
hydrolysis (Friedman et al., 1965) but
can be estimated using enzymic hydro-
lysis or mild acid hydrolysis followed by
chromatography on columns of Dowex-50
(NH4+, form), (Lawley and Shah, 1972).
These procedures have been used to
estimate the amount of methylation at
the 06-position of guanine in DNA
isolated from animals treated with DMN
(Fig. 3 and 4a; Table I). This base
accounts for 4-600 of the methylation
after DMN treatment but it was not
detected after MMS treatment (Fig. 5;
Table I).
Loss of 06-methylguanine from DNA
Estimations of 06 methylguanine from
the enzymic and mild hydrolytic proce-
dures described above (181 dpm and 167
dpm/,amol guanine respectively) indicate
that these procedures are reproducible.
However, chromatography of the free
base in this system produces a sharper
peak than with the corresponding deoxyri-
bonucleoside and forthis reason conversion
to the free base was adopted for estima-
tions of this methylated product at later
times (Fig. 4b and c). Under the experi-
mental conditions employed 06-methyl-
guanine was not detected by the fourth
day indicating that the base is lost from
liver DNA (Fig. 6). The stability of this
methylated base in DNA was tested by
incubating a sample of liver DNA
isolated from DMN treated rats killed
5 hours after the injection for 0 and 48
hours at 37 5°C in 10 mmol/l potassium
phosphate buffer (pH 7 0) and comparing
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FiC:. 5. Ion exchange chromatography on Dowex-50(NH4+, form) of a mild acid hydrolysate of
DNA isolated fiom the livers of rats killed 4 hours after an injection of [14C]MMS. Details are
givein undei Fig. 4.
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FIG. 6. Semi-logarithmic plot showing the loss of 06-methylguanine andl early peak (X1) mateiials from DNA isolatedl from the livers of rats which had beeni treated with [14C]DMIN (2 mg/kg) ancd killed at various times after the injection (see above). The limit of detection for 06-methylguanine is shown by the broken line, the arrows indicate analyses in which this methvlated base was not (letected; *, 06-methylguanine; 0, early peak (X1) materials.
the level of 06-methylation of guanine in
the 2 samples. The result, 185 and 193
dpm/,amol guanine for the zero time and
for the 48-hour samples respectively,
demonstrates that the base is stable under
these conditions. This is in good agree-
ment with the report of Lawley and
Thatcher (1970) that the base was stable
at 100°C for 20 minutes in phosphate
buffer at pH 7 0.
Loss of the early peak (X1) from DNA
HC104 hydrolysis and subsequent
chromatography on columns of Dowex-50
(H+, form) have been used to study the
loss of this material from DNA reacted
with DMN in vivo. The amount of
11
radioactive material present in the peak
(X1) has been assessed relative to guanine.
The 5-hour level is shown in Fig. 2a,
the 21-day level in Fig. 2b and the inter-
mediate values for X1 are given in Fig. 6.
This material is evidently lost from DNA
but at a much slower rate than that
observed for 06-methylguanine. Evidence
obtained from in vitro incubations ofDNA
isolated from DMN treated rats indicated
that peak (X1) radioactivity was stable
in DNA at 37°C for several days over a
range ofpH values (Margison et al., 1973).
Mletabolic labelling ofDNA
RNA studies described previously have
demonstrated radioactive labelling of the
-j
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purine bases via the 1-carbon pool (Crad-
dock and Magee, 1963; Whittle, 1969;
McElhone et al., 1971). In the present
work metabolic labelling of DNA
(expressed as dpm/,umol of purine bases)
was 5-6 times less (Fig. 7a and b) than
in the corresponding rRNA study
(McElhone et al., 1971). In DNA, thy-
mine, and not cytosine, was also labelled
by this process (Fig. 2a and b). Also, in
the present work and in the rRNA study
0-C
6
C)
go
-5
'a
la
half-life of the methylating agents in vivo
is relatively short and direct methylation,
even in the case of DMN, is over by about
the fifth hour after injection. Metabolic
incorporation on the other hand proceeds
more slowly and, apart from incorporation
not associated with cell division (e.g.
repair), the possibility exists that those
few cells in division would be preferenti-
ally labelled and may not be representa-
tive of the whole tissue. Further infor-
0 4 8 12 16 20 0 4 8 12 16 20
Time(days)
FIG. 7. Semi-logarithmic plot showing the time course for the incorporation of radioactivity into
adenine (*) and guanine (0) for rats treated with (a) [14C]MMS or (b) [14C]DMN. The bases were
isolated by chromatography on Dowex-50(H+, form) of HC104 hydrolysates of rat liver DNA
prepared at selected times after the injection of the methylating agents.
reported earlier (McElhone et al., 1971),
substantially moreradioactivity was incor-
porated into the purine bases after MMS
treatment and this was attributed to the
twenty-fold molar excess over the dosage
of DMN which, allowing for the specific
activity of the compounds, corresponded
to about 7 times more radioactivity
being administered in the MMS series.
There was considerable animal varia-
tion in the extent of metabolic labelling
of DNA but there was no evidence of a
significant loss of label over the 21-day
period (Fig. 7a and b). However, the
mation on this point is being obtained
from experiments with adult rats in which
radioactivity was introduced into liver
DNA at the neonatal stage using tritium-
labelled orotic acid.
DISCUSSION
Analysis of the products of methylation
Since breakdown of nucleic acids has
not been detected in the livers of these
animals, analyses obtained for the methy-
lation products should be representative
of the initial reaction in vivo. When
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comparison is made of the molar propor-
tions of the minor products 3-methyl-
cytosine, 3-methylguanine, 1-methyl-
adenine and 7-methyladenine, similar
levels of alkylation are observed after
reaction in vivo with MMS or DMN
(Table I). This is a disappointing obser-
vation, particularly in relation to 3-
methylcytosine, since there is strong
evidence for miscoding when polynucleo-
tides containing this modified base are
employed in polymerase systems in vitro
(Ludlum and Wilhelm, 1968; Ludlum,
1970, 1971; Singer and Fraenkel-Conrat,
1970). Further, in a previous report
substantially more methylation was
observed at the 3-position of cytosine in
rRNA from rat liver after MMS than after
treatment with the liver carcinogen DMN
(O'Connor et al., 1972). While methy-
lation at this position of cytosine is
potentially a mutagenic event on the
basis of miscoding in vitro (see above
references) and of virus and phage inacti-
vation in vivo (Singer and Fraenkel-
Conrat, 1969; Shooter, 1972); its import-
ance in liver carcinogenesis at present
seems of doubtful significance.
The only differences obtained from
these analyses relate to the higher levels
of early peak products to the presence of
06-methylguanine found after DMN treat-
ment (Table I, Fig. 2a, 3 and 4a) and the
higher levels of 3-methyladenine found
after MMS treatment (Table I, Fig. 5).
The presence of 06-methylation in DNA
after reaction in vivo with DMN and with
N-methyl-N'-nitro-N-nitrosoguanidine
(Lawley and Thatcher, 1970) supports
the contention that the process of 06-
alkylation could be important in carcino-
genesis (Loveless, 1969). Although
methylation at the 06-position of guanine
was not detected in these analyses after
MMS treatment, the results do not permit
the exclusion of a low level (less than 0 4%)
of this reaction product with the SN2
reagent.
The early peak accounted for 20% or
more of the total reaction products in
DNA after DMN treatment compared
with only 2% after treatment with MMS;
corresponding values for liver rRNA were
7 and 20% respectively (O'Connor et al.,
1972). In other chromatographic studies,
Schoental (1967) has observed a similar
material after reaction of DNA with
N-methyl-N-nitrosourethane in vivo and
in vitro and Craddock (1972) has com-
pared analyses of RNA and DNA from
DMN treated rats and found relative
amounts of early peak material corres-
ponding to our own results. This material
was probably derived from unknown
methylation products and not from meta-
bolic labelling via the 1-carbon pool
because in the present studies, taking
into account the relative dosage and
specific activities of the two alkylating
agents, a greater amount of radioactivity
was administered in the MMS treated
series and the resultant metabolic labelling
of purine was higher. Furthermore,
radioactivity introduced into DNA via
metabolic pathways was stable (Fig. 7a
and b), whereas the early peak products
were removed from DNA (e.g. by 4 days
less than 30% remained, Fig. 6). The
hypothesis that these products derive
from the alkylation of phosphate groups
in ribonucleic acids has already been
discussed (Lawley and Shah, 1972;
O'Connor et al., 1972).
Stability of the products of methylation
If methylation sites in DNA are to
have a protracted effect upon the meta-
bolism of liver cells, then it can be argued
that the reaction products must either
be stable or that they should cause mis-
coding before excision, or that, indirectly,
after excision some form of faulty repair
takes place. Any of these effects could
lead to a heritable change.
The low level of reaction at minor
sites after methylation with DMN pre-
cludes an analysis of stability except in
the case of 06-methylguanine and in this
case there is clear evidence that the base
waslostfrom DNA with ahalf-life approxi-
mating to 13 hours (Fig. 6). Data
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obtained for the early peak products also
indicated that an excision process was
taking place but at a slower rate than for
06-methylguanine.
The major alkylated base, 7-methyl-
guanine, was also lost from DNA with a
half-life of about 3 days (Margison et al.,
1973). The loss of 3-methyladenine is
being investigated. This base was easily
estimated in the 5 hour analysis of DNA
from DMN treated rats (Fig. 4a) but at
24 hours the amount present was at the
limits of detection (Fig. 4b). Since the
half-life for the depurination of this base
at pH 7 in vitro is about 24 hours (Lawley
and Brookes, 1963), this might imply the
presence of ain active excision system.
The rates of loss of reaction products from
liver DNA in vivo therefore follow the
sequence 3-methyladenine > 06-methyl-
guanine > peak (X1) > 7-methylguanine,
which is in agreement with the rate order
observed by Lawley and Orr (1971) for
the excision of methylated products from
the DNA of strains of Escherichia coli
treated with N-methyl-N'-nitro-N-nitro-
soguanidine. In this case the strain
showing the greater resistance to the drug
exhibited the more rapid excision.
The observation of similar relative
rates of excision of reaction products
for prokaryotes and eukaryotes suggests
the presence of similar mechanisms and
in the case of the chemically stable
products this implies an active process
which would operate either by product
excision or by a demethylation process.
Furthermore, the apparent need for the
rapid excision of 06-methylguanine would
lend support for the hypothesis tthat
06-methylation is a potential mutagenic
event (Loveless, 1969) against which
living organisms appear to have evolved
a protective mechanism. The excision
rates for the bacterial system were made
over a 1-3 hour period (Lawley and Orr,
1971) and although in hepatocytes the
excision times are longer, nevertheless
a half-life of about 13 hours for 06_
methylguanine is very rapid in relation
to the life-span of rat hepatocytes. The
cell renewal time for normal rat liver is
reported as 400-450 days (MacDonald,
1961) and the cell cycle time has been
estimated as 48 hours in the 8-week old
rat (Post and Hoffman, 1964). Aery few
cells would be in cycle at any one time
so that they could not play a significant
part in determining the half-life times
reported here.
General considerations
Single doses of DMN do not produce
tumours in the liver of adult rats, whereas
in the neonate a single dose given to mice
(Toth, Magee and Shubik, 1964) or to
rats (Della Porta and Terracini, 1969)
produce a high incidence of tumours. On
the other hand, exposure of adult rats to a
chronic treatment (50 parts/]06 in the
diet; equivalent to about 4 mg/kg/day)
does produce liver tumours (Magee and
Barnes, 1956). Adult rats given this
chronic exposure to the carcinogen showed
an increased rate ofturnover ofliver DNA
which was detected by the incorporation
of ['4C]labelled adenine into the DNA of
these animals (Craddock, 1 97 a). This
evidence suggests that events during cell
replication may be critical to the develop-
ment of tumours and further support for
this argument is provided by the obser-
vations of Craddock (197lb) that a single
injection of the agent given to rats after
partial hepatectomy, at times when DNA
synthesis was taking place, resulted in the
formation of tumours. Given that the
excision of 06-methylguanine proceeds
relatively rapidly then a period of DNA
synthesis would be essential before excision
is completed, if the altered base is to have
any effect, presumably through miscoding
(Loveless, 1969). The same argument
would hold for any other methylated base
with a mutagenic potential.
In conclusion, the comparison made
here between MMS and DMN treated
animals suggests that if reaction with
nucleic acids is germane to the process of
liver carcinogenesis then those modifica-
tionis to DNA structure most likely to be
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implicated are 06-methylguanine and the
unstable products yielding the early peak
materials (X1). Moreover, the detection
of excision processes for abnormal com-
ponents suggests that events leading to
thedevelopment oftumours mayberelated
to the efficiency of cellular excision
systems for certain products of alkylation
rather than to the level of alkylation
obtained at a particular reaction site.
Since 06-methylguanine is chemically
stable in DNA, it is possible that the
presence of a rapid excision process for
this base is important for maintaining
the integrity of cellular DNA.
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